Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Retatrutide is a 39-amino-acid peptide engineered from a GIP peptide backbone and modified to simultaneously activate three receptor systems
An angiogenic peptide could inadvertently support tumor vascularization in someone harboring undetected malignancy
The side effects of unapproved oral or injectable peptides are unknown, but they can be contaminated with heavy metals or be of questionable purity
Produced under controlled conditions, it is intended for analytical and laboratory research involving NNMT-related metabolic pathway studies
Who it fits: Patients who need cognitive performance support during a physical recovery cycle, or who want to address both systems simultaneously
